Beranda4DX • ASX
add
4DMedical Ltd
Tutup sebelumnya
$2,22
Rentang hari
$2,26 - $2,45
Rentang tahun
$0,23 - $2,55
Kapitalisasi pasar
1,26 M AUD
Volume Rata-Rata
3,22 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
ASX
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (AUD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,48 jt | -0,12% |
Biaya operasional | 13,34 jt | 10,01% |
Penghasilan bersih | -5,45 jt | 46,48% |
Margin laba bersih | -368,55 | 46,42% |
Penghasilan per saham | — | — |
EBITDA | -11,80 jt | -10,69% |
Tarif pajak efektif | 0,86% | — |
Neraca
Total aset
Total liabilitas
| (AUD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 6,88 jt | -77,52% |
Total aset | 94,81 jt | -21,00% |
Total liabilitas | 30,58 jt | -37,71% |
Total ekuitas | 64,24 jt | — |
Saham yang beredar | 493,53 jt | — |
Harga terhadap nilai buku | 15,86 | — |
Tingkat pengembalian aset | -31,64% | — |
Tingkat pengembalian modal | -43,76% | — |
Arus Kas
Perubahan kas bersih
| (AUD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -5,45 jt | 46,48% |
Kas dari operasi | -10,16 jt | -26,04% |
Kas dari investasi | -388,44 rb | -14,42% |
Kas dari pembiayaan | 6,01 jt | 2.670,69% |
Perubahan kas bersih | -4,54 jt | 47,47% |
Arus kas bebas | -5,40 jt | -4,62% |
Tentang
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Didirikan
2013
Situs
Karyawan
124